Home » Topics » BioWorld Science

BioWorld Science
RSS

New biomarkers identified for diagnosis of Cushing's syndrome

June 3, 2021

Epeleuton shows efficacy in preclinical models of atherosclerosis

June 3, 2021

Preclinical and early clinical characterization of VIB-7734

June 3, 2021

Phase II results presented from study comparing AZD-9567 versus prednisolone in active RA

June 3, 2021

Suzhou Zelgen Biosciences synthesizes new GTPase KRAS mutant inhibitors

June 3, 2021

Merck & Co. identifies nicotinic alpha7 receptor PAMs

June 3, 2021

Crinetics Pharmaceuticals synthesizes new melanocortin MC2 receptor antagonists

June 3, 2021

Nurix Therapeutics presents new PROTACs

June 3, 2021

Lophora ApS patents 5-HT2A receptor agonists

June 3, 2021

Wave Life Sciences presents promising preclinical data for its ADAR editing program

June 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Peptidream reveals milestone in Alnylam collaboration
BioWorld Science
Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.